Hyperthyroidism in Toxic Adenoma or Toxic Multinodular Goiter
This protocol addresses hyperthyroidism arising specifically from a toxic adenoma or a toxic multinodular goiter — autonomous nodules that produce excess thyroid hormone independently of TSH regulation.
Clinical Scenario
In patients with toxic adenoma or toxic multinodular goiter, antithyroid medications can control the symptoms of hyperthyroidism but do not induce remission. Because the underlying autonomous nodule continues to drive hormone overproduction, a definitive intervention is required in most cases.
Treatment Approach
The main treatment options center on ablative or surgical approaches to the overactive nodule or goiter. For patients with compressive symptoms from a nodule or enlarged goiter, a surgical route is favored. In select patients who cannot undergo these definitive options, long-term oral antithyroid medication may be considered — but the complete regimen, patient selection criteria, and sequencing are detailed in the full protocol.
References
- Antithyroid medications can control hyperthyroidism, but do not induce remission of hyperthyroidism associated with toxic adenoma or toxic multinodular goiter.
- Therefore, radioactive iodine ablation and thyroidectomy are the main treatment options for these conditions.
- Thyroidectomy is favored if a nodule or goiter causes compressive symptoms.
- Antithyroid medications may be used for long-term treatment in select patients who refuse ablation or who have a contraindication to thyroidectomy.